UB Paderborn / Katalog / Suche / in CDI

Once-Weekly Exenatide as Adjunct Treatment of Type 1 Diabetes Mellitus in Patients Receiving Continuous Subcutaneous Insulin Infusion Therapy

Canadian journal of diabetes, 2014-08, Vol.38 (4), p.269-272

2014

Link zum Volltext

Verfügbarkeit prüfen

Stability of U-500 regular insulin in prefilled syringes

Journal of the American Pharmacists Association, 2013-05, Vol.53 (3), p.304-306

2013

Link zum Volltext

Verfügbarkeit prüfen

Metyrapone for Long-Term Medical Management of Cushing’s Syndrome

Case reports in endocrinology, 2013-01, Vol.2013, p.782068-4

2013

Link zum Volltext

Verfügbarkeit prüfen

Pharmacist-run zoledronic acid clinic

American journal of health-system pharmacy, 2011-08, Vol.68 (15), p.1399-1403

2011

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of teriparatide in patients with resolved secondary hyperparathyroidism due to vitamin D deficiency

Endocrine practice, 2011-07, Vol.17 (4), p.568-573

2011

Link zum Volltext

Verfügbarkeit prüfen

Primer on Pramlintide, an Amylin Analog

The Diabetes educator, 2011-05, Vol.37 (3), p.426-431

2011

Link zum Volltext

Verfügbarkeit prüfen

Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of Radiotherapy to Block [CURB] oligoprogression): an open-label, randomised, controlled, phase 2 study

The Lancet (British edition), 2024-01, Vol.403 (10422), p.171-182

2024

Link zum Volltext

Verfügbarkeit prüfen

Survival of male genital cancers (prostate, testis and penis) in Europe 1999–2007: Results from the EUROCARE-5 study

European journal of cancer (1990), 2015-10, Vol.51 (15), p.2206-2216

2015

Link zum Volltext

Verfügbarkeit prüfen

Survival patterns in lung and pleural cancer in Europe 1999–2007: Results from the EUROCARE-5 study

European journal of cancer (1990), 2015-10, Vol.51 (15), p.2242-2253

2015

Link zum Volltext

Verfügbarkeit prüfen

Survival of adults with primary malignant brain tumours in Europe; Results of the EUROCARE-5 study

European journal of cancer (1990), 2015-10, Vol.51 (15), p.2231-2241

2015

Link zum Volltext

Verfügbarkeit prüfen

Rare neuroendocrine tumours: Results of the surveillance of rare cancers in Europe project

European journal of cancer (1990), 2013-07, Vol.49 (11), p.2565-2578

2013

Link zum Volltext

Verfügbarkeit prüfen

Comparative cancer survival information in Europe

European journal of cancer (1990), 2009-04, Vol.45 (6), p.901-908

2009

Link zum Volltext

Verfügbarkeit prüfen

A Pilot Study of Dose-Dense Paclitaxel With Trastuzumab and Lapatinib for Node-negative HER2-Overexpressed Breast Cancer

Clinical breast cancer, 2016-04, Vol.16 (2), p.87-94

2016

Link zum Volltext

Verfügbarkeit prüfen

A Feasibility Study of Bevacizumab plus Dose-Dense Doxorubicin―Cyclophosphamide (AC) Followed by Nanoparticle Albumin―Bound Paclitaxel in Early-Stage Breast Cancer

Clinical cancer research, 2011-05, Vol.17 (10), p.3398-3407

2011

Link zum Volltext

Verfügbarkeit prüfen

Abstract P2-16-07: Phase II study of pertuzumab, trastuzumab, and weekly paclitaxel in patients with metastatic HER2-overexpressing metastatic breast cancer with cardiac biomarker data

Cancer research (Chicago, Ill.), 2013-12, Vol.73 (24_Supplement), p.P2-P2-16-07

2013

Link zum Volltext

Verfügbarkeit prüfen

A virtual consult service to optimize clinical trial participation in patients with metastatic breast cancer

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.6601-6601

2014

Link zum Volltext

Verfügbarkeit prüfen

Phase II study of pertuzumab, trastuzumab, and weekly paclitaxel in patients with HER2-overexpressing metastatic breast cancer (MBC)

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.606-606

2013

Link zum Volltext

Verfügbarkeit prüfen

A translational study to investigate the association between smoking-induced lung inflammation and lung metastases (LM) from breast cancer (BC)

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.10514-10514

2012

Link zum Volltext

Verfügbarkeit prüfen

TBCRC 011: Targeting the androgen receptor (AR) for the treatment of AR+/ER-/PR- metastatic breast cancer (MBC)

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.TPS122-TPS122

2011

Link zum Volltext

Verfügbarkeit prüfen

Phase II study of weekly nanoparticle albumin bound (nab)paclitaxel with carboplatin and trastuzumab as 1st-line therapy for HER2-positive metastatic breast cancer (MBC)

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.1047-1047

2008

Link zum Volltext

Verfügbarkeit prüfen

Dose Dense Cyclophosphamide, Methotrexate, Fluorouracil is Feasible at 14-Day Intervals: A Pilot Study of Every-14-Day Dosing as Adjuvant Therapy for Breast Cancer

Clinical breast cancer, 2010-12, Vol.10 (6), p.440-444

2010

Link zum Volltext

Verfügbarkeit prüfen

Dose-dense (DD) doxorubicin and cyclophosphamide (AC) followed by weekly paclitaxel (P) with trastuzumab (T) and lapatinib (L) in HER2/neu-positive breast cancer is not feasible due to excessive diarrhea: updated results

Cancer research (Chicago, Ill.), 2009-01, Vol.69 (2_Supplement), p.2108

2009

Link zum Volltext

Verfügbarkeit prüfen

Left:right side ratio of endometriotic implants in the pelvis

European journal of obstetrics & gynecology and reproductive biology, 2003-11, Vol.111 (1), p.65-67

Parazzini, Fabio

2003

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Once-Weekly Exenatide as Adjunct Treatment of Type 1 Diabetes Mellitus in Patients Receiving Continuous Subcutaneous Insulin Infusion Therapy

Stability of U-500 regular insulin in prefilled syringes

Metyrapone for Long-Term Medical Management of Cushing’s Syndrome

Pharmacist-run zoledronic acid clinic

Efficacy of teriparatide in patients with resolved secondary hyperparathyroidism due to vitamin D deficiency

Primer on Pramlintide, an Amylin Analog

Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of Radiotherapy to Block [CURB] oligoprogression): an open-label, randomised, controlled, phase 2 study

Survival of male genital cancers (prostate, testis and penis) in Europe 1999–2007: Results from the EUROCARE-5 study

Survival patterns in lung and pleural cancer in Europe 1999–2007: Results from the EUROCARE-5 study

Survival of adults with primary malignant brain tumours in Europe; Results of the EUROCARE-5 study

Rare neuroendocrine tumours: Results of the surveillance of rare cancers in Europe project

Comparative cancer survival information in Europe

A Pilot Study of Dose-Dense Paclitaxel With Trastuzumab and Lapatinib for Node-negative HER2-Overexpressed Breast Cancer

A Feasibility Study of Bevacizumab plus Dose-Dense Doxorubicin―Cyclophosphamide (AC) Followed by Nanoparticle Albumin―Bound Paclitaxel in Early-Stage Breast Cancer

Abstract P2-16-07: Phase II study of pertuzumab, trastuzumab, and weekly paclitaxel in patients with metastatic HER2-overexpressing metastatic breast cancer with cardiac biomarker data

A virtual consult service to optimize clinical trial participation in patients with metastatic breast cancer

Phase II study of pertuzumab, trastuzumab, and weekly paclitaxel in patients with HER2-overexpressing metastatic breast cancer (MBC)

A translational study to investigate the association between smoking-induced lung inflammation and lung metastases (LM) from breast cancer (BC)

TBCRC 011: Targeting the androgen receptor (AR) for the treatment of AR+/ER-/PR- metastatic breast cancer (MBC)

Phase II study of weekly nanoparticle albumin bound (nab)paclitaxel with carboplatin and trastuzumab as 1st-line therapy for HER2-positive metastatic breast cancer (MBC)

Dose Dense Cyclophosphamide, Methotrexate, Fluorouracil is Feasible at 14-Day Intervals: A Pilot Study of Every-14-Day Dosing as Adjuvant Therapy for Breast Cancer

Dose-dense (DD) doxorubicin and cyclophosphamide (AC) followed by weekly paclitaxel (P) with trastuzumab (T) and lapatinib (L) in HER2/neu-positive breast cancer is not feasible due to excessive diarrhea: updated results

Left:right side ratio of endometriotic implants in the pelvis

Suchergebnisse filtern